This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (120)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Neurology  • Stroke  • Cardiovascular System  • Women's Health  • Women's Health, Other  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Sandeep Bansal, MD; Julie E. Buring, ScD; Nader Rifai, PhD; Samia Mora, MD, MHS; Frank M. Sacks, MD; Paul M Ridker, MD, MPH

JAMA. 2007;298:309-316.

Context  The association of triglycerides with incident cardiovascular disease remains controversial. Although triglyceride levels are typically obtained in the fasting state, postprandial hypertriglyceridemia may play an important role in atherosclerosis.

Objective  To determine the association of triglyceride levels (fasting vs nonfasting) and risk of future cardiovascular events.

Design, Setting, and Participants  Prospective study of 26 509 initially healthy US women (20 118 fasting and 6391 nonfasting) participating in the Women's Health Study, enrolled between November 1992 and July 1995 and undergoing follow-up for a median of 11.4 years. Triglyceride levels were measured in blood samples obtained at time of enrollment.

Main Outcome Measure  Hazard ratios for incident cardiovascular events (nonfatal myocardial infarction, nonfatal ischemic stroke, coronary revascularization, or cardiovascular death).

Results  At baseline, triglyceride levels in fasting as well as nonfasting women correlated with traditional cardiac risk factors and markers of insulin resistance. During a median follow-up of 11.4 years, 1001 participants experienced an incident cardiovascular event (including 276 nonfatal myocardial infarctions, 265 ischemic strokes, 628 coronary revascularizations, and 163 cardiovascular deaths), for an overall rate of 3.46 cardiovascular events per 1000 person-years of follow-up. After adjusting for age, blood pressure, smoking, and use of hormone therapy, both fasting and nonfasting triglyceride levels predicted cardiovascular events. Among fasting participants, further adjustment for levels of total and high-density lipoprotein cholesterol and measures of insulin resistance weakened this association (fully adjusted hazard ratio [95% confidence interval] for increasing tertiles of triglyceride levels: 1 [reference], 1.21 [0.96-1.52], and 1.09 [0.85-1.41] [P = .90 for trend]). In contrast, nonfasting triglyceride levels maintained a strong independent relationship with cardiovascular events in fully adjusted models (hazard ratio [95% confidence interval] for increasing tertiles of levels: 1 [reference], 1.44 [0.90-2.29], and 1.98 [1.21-3.25] [P = .006 for trend]). In secondary analyses stratified by time since participants' last meal, triglyceride levels measured 2 to 4 hours postprandially had the strongest association with cardiovascular events (fully adjusted hazard ratio [95% confidence interval] for highest vs lowest tertiles of levels, 4.48 [1.98-10.15] [P<.001 for trend]), and this association progressively decreased with longer periods of fasting.

Conclusions  In this cohort of initially healthy women, nonfasting triglyceride levels were associated with incident cardiovascular events, independent of traditional cardiac risk factors, levels of other lipids, and markers of insulin resistance; by contrast, fasting triglyceride levels showed little independent relationship.

Author Affiliations: Donald W. Reynolds Center for Cardiovascular Research (Drs Bansal, Mora, and Ridker), Leducq Center for Molecular and Genetic Epidemiology (Drs Rifai, Mora, and Ridker), Center for Cardiovascular Disease Prevention and Division of Preventive Medicine (Drs Bansal, Buring, Mora, and Ridker), and Division of Cardiology (Drs Mora and Ridker), Brigham and Women's Hospital; Department of Laboratory Medicine, Children's Hospital (Dr Rifai); and Department of Nutrition, Harvard School of Public Health (Dr Sacks), Boston, Massachusetts.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLES

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
Børge G. Nordestgaard, Marianne Benn, Peter Schnohr, and Anne Tybjærg-Hansen
JAMA. 2007;298(3):299-308.
ABSTRACT | FULL TEXT  

Triglycerides and Risk for Coronary Heart Disease
Patrick E. McBride
JAMA. 2007;298(3):336-338.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein
Mortensen et al.
Am. J. Clin. Nutr. 2009;90:41-48.
ABSTRACT | FULL TEXT  

APOC3 Mutation, Serum Triglyceride Concentrations, and Coronary Heart Disease
Tsai and Ordovas
Clin. Chem. 2009;55:1274-1276.
FULL TEXT  

Dyslipidemia and cardiovascular risk: the importance of early prevention
Miller
QJM 2009;0:hcp065v1-hcp065.
ABSTRACT | FULL TEXT  

Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice
Hartman et al.
J. Lipid Res. 2009;50:1090-1100.
ABSTRACT | FULL TEXT  

Large scale replication analysis of loci associated with lipid concentrations in a Japanese population
Nakayama et al.
J. Med. Genet. 2009;46:370-374.
ABSTRACT | FULL TEXT  

Fructose Consumption: Considerations for Future Research on Its Effects on Adipose Distribution, Lipid Metabolism, and Insulin Sensitivity in Humans
Stanhope and Havel
J. Nutr. 2009;139:1236S-1241S.
ABSTRACT | FULL TEXT  

Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)
Lee et al.
J. Biol. Chem. 2009;284:13735-13745.
ABSTRACT | FULL TEXT  

Endocrine and Metabolic Effects of Consuming Fructose- and Glucose-Sweetened Beverages with Meals in Obese Men and Women: Influence of Insulin Resistance on Plasma Triglyceride Responses
Teff et al.
J. Clin. Endocrinol. Metab. 2009;94:1562-1569.
ABSTRACT | FULL TEXT  

Proprotein Convertase Subtilisin Kexin Type 9 Null Mice Are Protected From Postprandial Triglyceridemia
Le May et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:684-690.
ABSTRACT | FULL TEXT  

Fasting and Nonfasting LDL Cholesterol: To Measure or Calculate?
Nordestgaard and Benn
Clin. Chem. 2009;55:845-847.
FULL TEXT  

Letter by Lund et al Regarding Article, "Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events"
Lund et al.
Circulation 2009;119:e384-e384.
FULL TEXT  

Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults
Ford et al.
Arch Intern Med 2009;169:572-578.
ABSTRACT | FULL TEXT  

Polyunsaturated Fatty Acids Modulate the Effect of TCF7L2 Gene Variants on Postprandial Lipemia
Warodomwichit et al.
J. Nutr. 2009;139:439-446.
ABSTRACT | FULL TEXT  

Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women
Mora et al.
Circulation 2009;119:931-939.
ABSTRACT | FULL TEXT  

Age at birth of first child and coronary heart disease risk factors at age 53 years in men and women: British birth cohort study
Hardy et al.
J. Epidemiol. Community Health 2009;63:99-105.
ABSTRACT | FULL TEXT  

Brief oral stimulation, but especially oral fat exposure, elevates serum triglycerides in humans
Mattes
Am. J. Physiol. Gastrointest. Liver Physiol. 2009;296:G365-G371.
ABSTRACT | FULL TEXT  

Gestational age and risk factors for cardiovascular disease: evidence from the 1958 British birth cohort followed to mid-life
Cooper et al.
Int J Epidemiol 2009;38:235-244.
ABSTRACT | FULL TEXT  

Adipocytokines and risk of stroke in older people: a nested case-control study
Stott et al.
Int J Epidemiol 2009;38:253-261.
ABSTRACT | FULL TEXT  

High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
El Harchaoui et al.
ANN INTERN MED 2009;150:84-93.
ABSTRACT | FULL TEXT  

Population-Based Genomewide Genetic Analysis of Common Clinical Chemistry Analytes
Chasman et al.
Clin. Chem. 2009;55:39-51.
ABSTRACT | FULL TEXT  

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Pollin et al.
Science 2008;322:1702-1705.
ABSTRACT | FULL TEXT  

Progressing From Risk Factors to Omics
Wilson
Circ Cardiovasc Genet 2008;1:141-146.
FULL TEXT  

Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
Freiberg et al.
JAMA 2008;300:2142-2152.
ABSTRACT | FULL TEXT  

Fasting and Nonfasting Lipid Levels: Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction
Langsted et al.
Circulation 2008;118:2047-2056.
ABSTRACT | FULL TEXT  

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
Fruchart et al.
Diabetes and Vascular Disease Research 2008;5:319-335.
ABSTRACT  

Accumulating short bouts of brisk walking reduces postprandial plasma triacylglycerol concentrations and resting blood pressure in healthy young men
Miyashita et al.
Am. J. Clin. Nutr. 2008;88:1225-1231.
ABSTRACT | FULL TEXT  

Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies
Livesey and Taylor
Am. J. Clin. Nutr. 2008;88:1419-1437.
ABSTRACT | FULL TEXT  

Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
Zacho et al.
NEJM 2008;359:1897-1908.
ABSTRACT | FULL TEXT  

Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
Mora et al.
Circulation 2008;118:993-1001.
ABSTRACT | FULL TEXT  

Apolipoprotein CIII and Atherosclerosis: Beyond Effects on Lipid Metabolism
Bobik
Circulation 2008;118:702-704.
FULL TEXT  

Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients
Kallio et al.
Innate Immunity 2008;14:247-253.
ABSTRACT  

Increased Plasma Apolipoprotein C-III Concentration Independently Predicts Cardiovascular Mortality: The Hoorn Study
Scheffer et al.
Clin. Chem. 2008;54:1325-1330.
ABSTRACT | FULL TEXT  

Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk
Despres et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1039-1049.
ABSTRACT | FULL TEXT  

Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study
Mozaffarian et al.
Arch Intern Med 2008;168:969-978.
ABSTRACT | FULL TEXT  

Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals
Stanhope et al.
Am. J. Clin. Nutr. 2008;87:1194-1203.
ABSTRACT | FULL TEXT  

Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p
Broadbent et al.
Hum Mol Genet 2008;17:806-814.
ABSTRACT | FULL TEXT  

Association of serum lipid indices with large artery atherosclerotic stroke
Bang et al.
Neurology 2008;70:841-847.
ABSTRACT | FULL TEXT  

Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance
Reyes et al.
J. Lipid Res. 2008;49:670-678.
ABSTRACT | FULL TEXT  

Rationale, Design, and Methodology of the Women's Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women
Ridker et al.
Clin. Chem. 2008;54:249-255.
ABSTRACT | FULL TEXT  

Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health
O'Keefe et al.
J Am Coll Cardiol 2008;51:249-255.
ABSTRACT | FULL TEXT  

Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?
Ridker
Clin. Chem. 2008;54:11-13.
FULL TEXT  

Fasting versus Nonfasting Triglycerides: Implications for Laboratory Measurements
Warnick and Nakajima
Clin. Chem. 2008;54:14-16.
FULL TEXT  

Lipid, Glycemic, and Insulin Responses to Meals Rich in Saturated, cis-Monounsaturated, and Polyunsaturated (n-3 and n-6) Fatty Acids in Subjects With Type 2 Diabetes
Shah et al.
Diabetes Care 2007;30:2993-2998.
ABSTRACT | FULL TEXT  

Nonfasting Triglycerides and Cardiovascular Risk
Yancy et al.
JAMA 2007;298:2004-2004.
FULL TEXT  

Nonfasting Triglycerides and Cardiovascular Risk
Tsarpalis
JAMA 2007;298:2004-2005.
FULL TEXT  

Triglycerides and Coronary Heart Disease Revisited (Again)
Criqui
ANN INTERN MED 2007;147:425-427.
FULL TEXT  

Nonfasting Triglycerides as an Indicator of Cardiovascular Risk
JWatch Women's Health 2007;2007:2-2.
FULL TEXT  

Are Nonfasting Better Than Fasting Triglyceride Levels at Predicting Cardiac Events?
Journal Watch Cardiology 2007;2007:1-1.
FULL TEXT  

Triglycerides and Risk for Coronary Heart Disease
McBride
JAMA 2007;298:336-338.
FULL TEXT